Restraining Wnt activation and intestinal tumorigenesis by a Rab35 dependent GTPase relay
Siamak Redhai,Tianyu Wang,Kim. E Boonekamp,Saskia Reuter,Tümay Capraz,Svenja Leible,Shivohum Bahaguna,Fillip Port,Bojana Pavlović,Michaela Holzem,Roman M. Doll,Niklas Rindtorff,Erica Valentini,Barbara Schmitt,Karsten Richter,Ulrike Engel,Wolfgang Huber,Michael Boutros
DOI: https://doi.org/10.1101/2024.02.05.578891
2024-02-06
Abstract:Maintenance of homeostatic processes ensure curtailment of intestinal tumorigenesis. Inactivating mutations to Adenomatous Polyposis Coli ( ) result in aberrantly activated Wnt signalling and initiates colorectal cancer (CRC) in approx. 80% of cases, yet our understanding of the subcellular mechanisms that modulate dysregulated pathway activity is limited. Here, using a conditional genetic screen, we identify Rab35 GTPase as a novel tumour suppressor that modulates regional Wnt activity after loss of in progenitor cells. Single cell analysis revealed that progenitor cells respond to depletion by increasing the expression of a GTPase activating protein, which we named , and triggering Rab35 disassociation from the plasma membrane. Mechanistically, we demonstrate that Rab35 controls the localisation and activation of the Rho GTPase, Cdc42, which functions as a relay to regulate JNK signalling. This in turn tunes the Wnt pathway upstream of β-catenin to direct proliferation and differentiation of progenitor cells. Importantly, we show that maintaining active JNK signalling is important for the propagation of mutant mouse colon organoids. Our findings highlight a novel GTPase cascade that sustains aberrant Wnt activity in specific segments of the intestine and provides impetus to therapeutically exploit this pathway to target CRC.
Cancer Biology